News
1 February 2020
IMMAGINA Raises 1M €
In February 2020 IMMAGINA BioTechnology raised 1M Euro from existing investors and new, undisclosed EU-based investors. The Company has raised about 2M Euro to date.
Press release: IMMAGINA BIOTECHNOLOGY: ONE MILLION
EUROS OF PRIVATE INVESTMENTS IN AN ITALIAN BIOTECH START-UP
IMMAGINA BioTechnology S.r.l. (The Ribosome
Company) offers an exclusive platform dedicated to pharmaceutical and
biomedical research capable of isolating specific cellular components (active
ribosomes), i.e. molecular printers that read a text (called RNA) and produce
the functional building blocks (called proteins) of every living cell. The
platform currently includes 5 research kits and some accessory products for
purification and sequencing of biological samples. These products, unique on
the market, are able to give an image of what healthy or diseased cells
produce. IMMAGINA products are currently sold worldwide to pharmaceutical
companies and public and private research centers for cutting-edge studies in
the biomedical sector.
INVESTMENT FOR GROWTH
A capital injection of approximately one million
euros was recently completed to support the development plans of IMMAGINA
BioTechnology S.r.l., a start-up in the Biotech sector born and raised in
Trentino Alto Adige. To subscribe the investment were the existing shareholders
(including Mauro Cogoli, Giovanni Zobele, Technicon S.p.A., Hermann Hauser
Investment Gmbh) and new investors from Switzerland, Austria, Germany, the
South Tyrolean tba-network and the rest of Italy. The capital increase and
investment are intended to support commercial and marketing development at a
global level, in addition to constant product innovation. In fact, IMMAGINA
BioTechnology S.r.l. recently signed an agreement with the British company
Oxford Nanopore Technologies for a collaborative project on RNA sequencing. The
activity of Immagina BioTechnology S.r.l. takes place in the Laboratory of
Biomarker Studies and Structure Analysis for Health (LaBSSAH), a joint
laboratory between the University of Trento / Bruno Kessler Foundation (FBK) /
National Council Research Institute - CNR-IBF Institute of Biophysics, and
established within the FBK facilities in Trento.
IMMAGINA has been operating commercially since
the beginning of 2019 and is currently made up of a team of 6 people in
expansion to support business needs. This last investment is added to the first
investments of 2017, to the support of Banca Intesa and to a contribution LP6 /
99 which were dedicated to the development of the properties intellectuals and
platform.